Application 209672
- Type
- ANDA
- Sponsor
- CIPLA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | VALGANCICLOVIR HYDROCHLORIDE | VALGANCICLOVIR HYDROCHLORIDE | TABLET;ORAL | EQ 450MG BASE | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A209672-001 | VALGANCICLOVIR HYDROCHLORIDE | VALGANCICLOVIR HYDROCHLORIDE | EQ 450MG BASE | TABLET / ORAL | 2018-11-09 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A209672-001 | VALGANCICLOVIR HYDROCHLORIDE | EQ 450MG BASE | TABLET / ORAL | 2018-11-09 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209672-001 | VALGANCICLOVIR HYDROCHLORIDE | EQ 450MG BASE | TABLET / ORAL | 2018-11-09 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A209672-001 | VALGANCICLOVIR HYDROCHLORIDE | EQ 450MG BASE | TABLET / ORAL | 2018-11-09 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A209672-001 | VALGANCICLOVIR HYDROCHLORIDE | EQ 450MG BASE | TABLET / ORAL | 2018-11-09 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A209672-001 | VALGANCICLOVIR HYDROCHLORIDE | EQ 450MG BASE | TABLET / ORAL | 2018-11-09 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A209672-001 | VALGANCICLOVIR HYDROCHLORIDE | EQ 450MG BASE | TABLET / ORAL | 2018-11-09 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A209672-001 | VALGANCICLOVIR HYDROCHLORIDE | EQ 450MG BASE | TABLET / ORAL | 2018-11-09 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A209672-001 | VALGANCICLOVIR HYDROCHLORIDE | EQ 450MG BASE | TABLET / ORAL | 2018-11-09 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A209672-001 | VALGANCICLOVIR HYDROCHLORIDE | EQ 450MG BASE | TABLET / ORAL | 2018-11-09 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A209672-001 | VALGANCICLOVIR HYDROCHLORIDE | EQ 450MG BASE | TABLET / ORAL | 2018-11-09 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A209672-001 | VALGANCICLOVIR HYDROCHLORIDE | EQ 450MG BASE | TABLET / ORAL | 2018-11-09 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A209672-001 | VALGANCICLOVIR HYDROCHLORIDE | EQ 450MG BASE | TABLET / ORAL | 2018-11-09 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A209672-001 | VALGANCICLOVIR HYDROCHLORIDE | EQ 450MG BASE | TABLET / ORAL | 2018-11-09 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A209672-001 | VALGANCICLOVIR HYDROCHLORIDE | EQ 450MG BASE | TABLET / ORAL | 2018-11-09 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A209672-001 | VALGANCICLOVIR HYDROCHLORIDE | EQ 450MG BASE | TABLET / ORAL | AB | 2018-11-09 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | A209672-001 | VALGANCICLOVIR HYDROCHLORIDE | EQ 450MG BASE | TABLET / ORAL | AB | 2018-11-09 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | A209672-001 | VALGANCICLOVIR HYDROCHLORIDE | EQ 450MG BASE | TABLET / ORAL | AB | 2018-11-09 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | A209672-001 | VALGANCICLOVIR HYDROCHLORIDE | EQ 450MG BASE | TABLET / ORAL | AB | 2018-11-09 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | A209672-001 | VALGANCICLOVIR HYDROCHLORIDE | EQ 450MG BASE | TABLET / ORAL | AB | 2018-11-09 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | A209672-001 | VALGANCICLOVIR HYDROCHLORIDE | EQ 450MG BASE | TABLET / ORAL | AB | 2018-11-09 | 782e0a99824c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A209672-001 | VALGANCICLOVIR HYDROCHLORIDE | EQ 450MG BASE | TABLET / ORAL | AB | 2018-11-09 | 87673890dc5c… | |
| 2021-03-12 10:30 UTC | 2021-03 | A209672-001 | VALGANCICLOVIR HYDROCHLORIDE | EQ 450MG BASE | TABLET / ORAL | AB | 2018-11-09 | 5aa47cf7b7d7… | |
| 2020-12-22 03:56 UTC | 2020-12 | A209672-001 | VALGANCICLOVIR HYDROCHLORIDE | EQ 450MG BASE | TABLET / ORAL | AB | 2018-11-09 | 8869cabd3fbd… | |
| 2020-11-12 02:37 UTC | 2020-11 | A209672-001 | VALGANCICLOVIR HYDROCHLORIDE | EQ 450MG BASE | TABLET / ORAL | AB | 2018-11-09 | c0c555d07b60… | |
| 2019-12-14 00:12 UTC | 2019-12 | A209672-001 | VALGANCICLOVIR HYDROCHLORIDE | EQ 450MG BASE | TABLET / ORAL | AB | 2018-11-09 | 3f01610625f2… | |
| 2019-09-15 20:21 UTC | 2019-09 | A209672-001 | VALGANCICLOVIR HYDROCHLORIDE | EQ 450MG BASE | TABLET / ORAL | AB | 2018-11-09 | b00525d2431f… | |
| 2019-07-19 19:46 UTC | 2019-07 | A209672-001 | VALGANCICLOVIR HYDROCHLORIDE | EQ 450MG BASE | TABLET / ORAL | AB | 2018-11-09 | ea99ee380514… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A209672-001 | VALGANCICLOVIR HYDROCHLORIDE | EQ 450MG BASE | TABLET / ORAL | 2018-11-09 | 6a51e52b5d6a… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A209672-001 | VALGANCICLOVIR HYDROCHLORIDE | EQ 450MG BASE | TABLET / ORAL | 2018-11-09 | 1c564ffb4f44… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A209672-001 | VALGANCICLOVIR HYDROCHLORIDE | EQ 450MG BASE | TABLET / ORAL | 2018-11-09 | ea1830bbd6c7… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A209672-001 | VALGANCICLOVIR HYDROCHLORIDE | EQ 450MG BASE | TABLET / ORAL | 2018-11-09 | a72a2bbeb626… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A209672-001 | VALGANCICLOVIR HYDROCHLORIDE | EQ 450MG BASE | TABLET / ORAL | 2018-11-09 | 9b2671bbb829… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A209672-001 | VALGANCICLOVIR HYDROCHLORIDE | EQ 450MG BASE | TABLET / ORAL | AB | 2018-11-09 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A209672-001 | VALGANCICLOVIR HYDROCHLORIDE | EQ 450MG BASE | TABLET / ORAL | AB | 2018-11-09 | 3f0d92c62455… | |
| 2023-05-13 08:27 UTC | 2023-05 | A209672-001 | VALGANCICLOVIR HYDROCHLORIDE | EQ 450MG BASE | TABLET / ORAL | AB | 2018-11-09 | 053a50430f4f… | |
| 2023-01-26 05:58 UTC | 2023-01 | A209672-001 | VALGANCICLOVIR HYDROCHLORIDE | EQ 450MG BASE | TABLET / ORAL | AB | 2018-11-09 | 3bdfa0b2c4d7… | |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A209672-001 | VALGANCICLOVIR HYDROCHLORIDE | EQ 450MG BASE | TABLET / ORAL | AB | 2018-11-09 | 3a93d1ddd44b… | |
| 2022-10-28 04:53 UTC | 2022-10 | A209672-001 | VALGANCICLOVIR HYDROCHLORIDE | EQ 450MG BASE | TABLET / ORAL | AB | 2018-11-09 | f41ea6bd6efb… | |
| 2022-09-29 23:25 UTC | 2022-09 | A209672-001 | VALGANCICLOVIR HYDROCHLORIDE | EQ 450MG BASE | TABLET / ORAL | AB | 2018-11-09 | e64feba35796… | |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A209672-001 | VALGANCICLOVIR HYDROCHLORIDE | EQ 450MG BASE | TABLET / ORAL | AB | 2018-11-09 | cb3db0bc1861… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A209672-001 | AB | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A209672-001 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A209672-001 | AB | 1 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | A209672-001 | AB | 1 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | A209672-001 | AB | 1 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | A209672-001 | AB | 1 | 782e0a99824c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A209672-001 | AB | 1 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | A209672-001 | AB | 1 | 5aa47cf7b7d7… |
| 2020-12-22 03:56 UTC | 2020-12 | A209672-001 | AB | 1 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | A209672-001 | AB | 1 | c0c555d07b60… |
| 2019-12-14 00:12 UTC | 2019-12 | A209672-001 | AB | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | A209672-001 | AB | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | A209672-001 | AB | 1 | ea99ee380514… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A209672-001 | AB | 1 | a67488948f0b… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A209672-001 | AB | 1 | 3f0d92c62455… |
| 2023-05-13 08:27 UTC | 2023-05 | A209672-001 | AB | 1 | 053a50430f4f… |
| 2023-01-26 05:58 UTC | 2023-01 | A209672-001 | AB | 1 | 3bdfa0b2c4d7… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A209672-001 | AB | 1 | 3a93d1ddd44b… |
| 2022-10-28 04:53 UTC | 2022-10 | A209672-001 | AB | 1 | f41ea6bd6efb… |
| 2022-09-29 23:25 UTC | 2022-09 | A209672-001 | AB | 1 | e64feba35796… |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A209672-001 | AB | 1 | cb3db0bc1861… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| VALGANCICLOVIR HYDROCHLORIDE | VALGANCICLOVIR | Somerset Therapeutics, LLC | b856bfaf-ec6b-4171-81c4-b9b07f780084 | 2026-01-22 | Boxed warning, Warnings, Adverse reactions | VALGANCICLOVIR HYDROCHLORIDE |
| VALGANCICLOVIR HYDROCHLORIDE | VALGANCICLOVIR HYDROCHLORIDE | NorthStar Rx LLC | 1cc09039-dcd6-4721-abd4-411535ccf442 | 2026-01-20 | Boxed warning, Warnings, Adverse reactions | VALGANCICLOVIR HYDROCHLORIDE VALGANCICLOVIR HYDROCHLORIDE |
| Valganciclovir hydrochloride for Oral | VALGANCICLOVIR HYDROCHLORIDE | AvKARE | 07eb5abf-2322-4fb9-e063-6394a90a2311 | 2026-01-19 | Boxed warning, Warnings, Adverse reactions | VALGANCICLOVIR HYDROCHLORIDE |
| Valganciclovir | VALGANCICLOVIR HYDROCHLORIDE | AvKARE | 0d0bbc91-27f6-29bc-e063-6394a90a0027 | 2026-01-19 | Boxed warning, Warnings, Adverse reactions | VALGANCICLOVIR HYDROCHLORIDE |
| VALGANCICLOVIR HYDROCHLORIDE | VALGANCICLOVIR HYDROCHLORIDE | Aurobindo Pharma Limited | 8d2ffc05-2fbc-41f8-8656-fbc0bfa7ad83 | 2026-01-06 | Boxed warning, Warnings, Adverse reactions | VALGANCICLOVIR HYDROCHLORIDE VALGANCICLOVIR HYDROCHLORIDE |
| Valcyte | VALGANCICLOVIR | H2-Pharma, LLC | 4c517a39-2ded-4c5a-8d56-276853414b31 | 2025-12-08 | Boxed warning, Warnings, Adverse reactions | VALGANCICLOVIR HYDROCHLORIDE |
| Valganciclovir hydrochloride | VALGANCICLOVIR HYDROCHLORIDE | Ajanta Pharma USA Inc. | 178a014b-92c7-44a7-abb8-95d89a2feb8f | 2025-11-30 | Boxed warning, Warnings, Adverse reactions | Valganciclovir hydrochloride VALGANCICLOVIR HYDROCHLORIDE |
| Valganciclovir | VALGANCICLOVIR HYDROCHLORIDE | Strides Pharma Science Limited | 89a934f0-85a3-44c1-82e5-d09d1738e08d | 2025-08-01 | Boxed warning, Warnings, Adverse reactions | VALGANCICLOVIR HYDROCHLORIDE |
| Valganciclovir hydrochloride for Oral | VALGANCICLOVIR HYDROCHLORIDE | Actavis Pharma, Inc. | 92281301-5fb5-4eea-8766-4863e241c234 | 2025-06-27 | Boxed warning, Warnings, Adverse reactions | VALGANCICLOVIR HYDROCHLORIDE |
| VALGANCICLOVIR | VALGANCICLOVIR HYDROCHLORIDE | NorthStar RxLLC | 2e8a4d62-2098-4ffe-a154-e45cfdfe6c4c | 2024-04-11 | Boxed warning, Warnings, Adverse reactions | VALGANCICLOVIR HYDROCHLORIDE |
| VALGANCICLOVIR HYDROCHLORIDE | VALGANCICLOVIR | Granules Pharmaceuticals Inc. | 39452b74-161d-4525-a0f7-fe486f001513 | 2024-02-29 | Boxed warning, Warnings, Adverse reactions | VALGANCICLOVIR HYDROCHLORIDE |
| Valganciclovir | VALGANCICLOVIR HYDROCHLORIDE | Strides Pharma Science Limited | 390691b2-3db0-4b9f-934f-120674726f14 | 2024-01-26 | Boxed warning, Warnings, Adverse reactions | VALGANCICLOVIR HYDROCHLORIDE |
| Valganciclovir | VALGANCICLOVIR HYDROCHLORIDE | American Health Packaging | 0e30509f-add6-43c8-9e1d-e10c55a207e6 | 2023-08-22 | Boxed warning, Warnings, Adverse reactions | VALGANCICLOVIR HYDROCHLORIDE |
| valganciclovir hydrochloride | VALGANCICLOVIR HYDROCHLORIDE | Dr. Reddy's Laboratories Inc | e30ae2b2-dad2-39ba-6bc7-400807791ab0 | 2022-12-23 | Boxed warning, Warnings, Adverse reactions | valganciclovir hydrochloride VALGANCICLOVIR HYDROCHLORIDE |
| VALGANCICLOVIR | VALGANCICLOVIR HYDROCHLORIDE | Camber Pharmaceuticals, Inc. | 28703782-9f48-4866-a32d-1604da9dee6b | 2022-10-10 | Boxed warning, Warnings, Adverse reactions | VALGANCICLOVIR HYDROCHLORIDE |
| valganciclovir hydrochloride | VALGANCICLOVIR HYDROCHLORIDE | Novadoz Pharmaceuticals LLC | 614ff447-7e5f-4ea6-ba85-ec1f6497b360 | 2022-01-29 | Boxed warning, Warnings, Adverse reactions | valganciclovir hydrochloride VALGANCICLOVIR HYDROCHLORIDE |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 69097-277 | Valganciclovir | Valganciclovir | Cipla USA Inc. | ANDA | Current |
| 69097-277 | Valganciclovir | Valganciclovir | Cipla USA Inc. | ANDA | Current |
| 69097-277 | Valganciclovir | Valganciclovir | Cipla USA Inc. | ANDA | Current |
| 69097-277 | Valganciclovir | Valganciclovir | Cipla USA Inc. | ANDA | Current |